It is important to acknowledge at the outset that the term ‘seronegative RA’ as conventionally used refers specifically to RF/ACPA-negative disease and should not be equated with ‘truly autoantibody-negative’ or ‘immunonegative’ RA. This evidence concerns the gene PRTN3 and rheumatoid arthritis.